GSK3-beta inhibitors as novel drug candidates to arrest Arrhythmogenic Cardiomyopathy (AC): pilot study in a novel knock-in mouse model of Desmoplakin-linked AC

PALMA, NIKOLSA
2020/2021

2020
GSK3-beta inhibitors as novel drug candidates to arrest Arrhythmogenic Cardiomyopathy (AC): pilot study in a novel knock-in mouse model of Desmoplakin-linked AC
Arrhythmogenic
Cardiomyopathy
GSK3-beta inhibitors
File in questo prodotto:
Non ci sono file associati a questo prodotto.

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/6342